Neuroprotective treatment application on the 1st rehabilitayion stage of patients with ischemic stroke
To evaluate an influence of neuroprotective treatment (example - preparation Cellex) on course at the 1st rehabilitation stage of patients with ischemic stroke. The double-blind, placebo controlled, randomized multi-center researches was organized in 8 Russian clinical sites and were involved 480 patients with ischemic stroke at the age of 35-80. There search showed that in group of the patients under prescription of Cellex marked authentically better result with regress of movement, visual, speech and cognitive disordersas compared with patients who were accepting placebo during the standard base therapy. According to the findings Cellex is recommended for rehabilitationof patients with ischemic stroke.